Clinical Trials Directory

Trials / Unknown

UnknownNCT03704506

Registration of the Study of Reyanning Mixture

A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial of the Efficacy and Safety of Treating Acute Tonsillitis With Reyanning Mixture Alone/in Combination With Antibiotics.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
144 (estimated)
Sponsor
China Academy of Chinese Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of treating with acute tonsillitis using Reyanning mixture alone/in combination with antibiotics, and its function of reducing the use of antibiotics.

Detailed description

In order to evaluate the efficacy,safety and the function of reducing the use of antibiotics of Reyanning mixture (a mixture of Chinese herbal medicine) in treating with acute tonsillitis, a randomized, double-blind, placebo-controlled, multicenter clinical trials will be established. According to the relevant regulations of the China Food and Drug Administration(CFDA), 144 cases need to be registered at least. The aim population is who suffering of acute tonsillitis from October 2018 to December 2019.These cases will be randomly divided into treatment group 1(Reyanning mixture +amoxil capsule simulator),treatment group 2(Reyanning mixture +amoxil capsule) and control group(Reyanning mixture simulator +amoxil capsule).Each group will be treated for 7 days and followed up for 3 times . The main indicators include the recovery time/rate and antibiotic duration/dosage. And the vanish rate of single symptom/physical sign, the ratio of white blood cell count(WBC) recovery, the time of fever will be observed as well.

Conditions

Interventions

TypeNameDescription
DRUGReyanning mixtureReyanning mixture , 20ml by mouth , 3 times per day for 7 days
DRUGamoxil capsuleamoxil capsule , 0.5g by mouth , 3 times per day for 7 days
DRUGReyanning mixture simulatorReyanning mixture simulator , 20ml by mouth , 3 times per day for 7 days
DRUGamoxil capsule simulatoramoxil capsule simulator , 0.5g by mouth , 3 times per day for 7 days

Timeline

Start date
2018-10-22
Primary completion
2019-06-30
Completion
2019-12-31
First posted
2018-10-12
Last updated
2018-10-12

Source: ClinicalTrials.gov record NCT03704506. Inclusion in this directory is not an endorsement.